Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05926544 · ClinicalTrials.gov registry record · NA
COVID-19 Vaccine Hesitancy Counseling Intervention for Pharmacists
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Terminated
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT05926544 is a NA study that was terminated before completion, run by University of North Carolina, Chapel Hill. The registered enrollment target is 16 participants.
The verdict
NCT05926544, a NA study, was terminated before completion, sponsored by University of North Carolina, Chapel Hill.
- TERMINATED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to test if virtual facilitation (e.g., video coaching) increases rural pharmacists' ability to implement COVID-19 vaccine hesitancy counseling when compared to a "standard" implementation approach (e.g., training and dissemination of implementation support tools) in rural pharmacies. The main question it aims to answer is if virtual facilitation improves fidelity to a newly developed vaccine hesitancy counseling intervention when compared to standard implementation. All participants will begin in the standard implementation condition, where they will complete a webinar on COVID-19 vaccinations and a 30-minute online training on vaccine hesitancy communication. After standard implementation, they will switch to the virtual facilitation condition where they will be assigned a virtual coach to help them with implementing the intervention. There will be four fidelity observations per each 8-week intervention period to determine whether pharmacists are implementing the intervention as intended. Researchers will compare fidelity between the standard and virtual facilitation conditions.
Interventions
- BEHAVIORAL Standard implementation webinar and online training
- BEHAVIORAL Virtual facilitation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2023-10-04 |
| Est. Completion | 2024-06-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05926544
The ClinicalTrials.gov registry entry for NCT05926544 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard implementation webinar and online training is the first listed.
NCT05926544 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05926544 about?
NCT05926544 is a clinical study titled "COVID-19 Vaccine Hesitancy Counseling Intervention for Pharmacists". The goal of this clinical trial is to test if virtual facilitation (e.g., video coaching) increases rural pharmacists' ability to implement COVID-19 vaccine hesitancy counseling when compared to a "standard" implementation approach (e.g., training and dissemination of implementation support tools) i...
What is the current status of trial NCT05926544?
This trial is currently terminated. It is a NA study. The enrollment target is 16 participants. The study started on 2023-10-04. Estimated completion is 2024-06-20.
What interventions are being tested in trial NCT05926544?
The interventions under investigation include: Standard implementation webinar and online training (BEHAVIORAL), Virtual facilitation (BEHAVIORAL).
Who is sponsoring clinical trial NCT05926544?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.